NCT01518218|CompletedPhase 2DMC
Loading search results
Sponsor study identifier
interventional
40
1 country
1
Study Start
March 2006
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
March 2007
Actual (reported)Study Completion
December 2009
Actual (reported)The objective of this study is to evaluate the effectiveness of 1-year administration of laying-on-of-hands on the morbidity and mortality of patients with sickle cell disease in Africa.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 2009
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
March 2006
Date type not reportedThis date has not been verified as actual or estimated.
March 2007
Actual (reported)December 2009
Actual (reported)January 21, 2012
Actual (reported)January 25, 2012
Actual (reported)disease-related episodes and mortality
3 years and 9 months
blood data
1 year
Patients of this arm received laying-on-of-hands twice a day (45 minutes each) every weekday for 1year, and received conventional medical treatment if necessary.
Patients of this arm did not receive any alternatives other than conventional treatment.
The intervention group received laying-on-of-hands every weekday for 1 year along with conventional medicine. The control group did not undergo any alternatives to OPT.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
The national medical center for sickle cell disease
Kinshasa, Democratic Republic of the Congo
Minga TM, Koto FK, Egboki H, Suzuki K. Effectiveness of biofield therapy for individuals with sickle cell disease in Africa. Altern Ther Health Med. 2014 Jan-Feb;20(1):20-6.
Kodondi K Koto, MD, PhD
The Institute of Scientific Research for Health, Kinshasa
40 participants (actual enrollment reported by the registry).
First Submitted
January 21, 2012
First Posted
January 25, 2012
Study Start
March 2006
Date type not reportedThis date has not been verified as actual or estimated.
L-Glutamine Therapy for Sickle Cell Anemia and Sickle ß0 Thalassemia
Contact the study team to confirm eligibility.
Primary Completion
March 2007
Actual (reported)Study Completion
December 2009
Actual (reported)Last Updated
April 13, 2015
Record last verified: 2012-01
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: